These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7009161)

  • 21. Association of host immunoglobulins with solid tumours in vivo.
    James K; Bessos YH; Merriman J
    Br J Cancer; 1979 Nov; 40(5):689-700. PubMed ID: 315785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 23. Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.
    Currie GA
    Br Med J; 1970 Feb; 1(5695):541-4. PubMed ID: 5435189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of whole body irradiation in mice treated with C. parvum.
    Basić I; Milas L
    Eur J Cancer (1965); 1979 Jun; 15(6):901-8. PubMed ID: 499277
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.
    Stone HB; Peters LJ; Milas L
    J Natl Cancer Inst; 1979 Nov; 63(5):1229-35. PubMed ID: 291749
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 29. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
    Suit HD; Sedlacek R; Wagner M; Orsi L
    Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy of mice bearing myeloma and EL4 leukemia].
    Kitasato M
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):958-65. PubMed ID: 2447213
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunomodulating properties of Acnevac vaccine].
    Marcinkiewicz J; Bryniarski K; Nowak B; Dzielska D; Payerhin F
    Med Dosw Mikrobiol; 1991; 43(3-4):167-74. PubMed ID: 1840429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of purified cell walls from Corynebacterium parvum.
    Riveros-Moreno V; Bomford R; Scott MT
    J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.
    Szymaniec S; James K
    Br J Cancer; 1976 Jan; 33(1):36-50. PubMed ID: 1252329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.